• 0
MENU
Cart Details

Nausifar MPS Tablet

  • Home
  • Nausifar MPS Tablet

Product Informations: Nausifar MPS Tablet

In Vomiting Nausifar MPS Tablet blocks the action of chemicals in the body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused due to some medicines or cancer treatment. This medicine helps you recover more comfortably from cancer treatments such as radiation therapy or chemotherapy. It is also effective at preventing nausea and vomiting after an operation (in adults only). The dose will depend on what you are being treated for but always take this medicine as it is prescribed.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nausifar MPS Tablet is to be taken empty stomach.
Nausifar MPS Tablet is a combination medicine used in the treatment of vomiting. It also promotes the movement of food in the stomach to prevent nausea or vomiting. It also allows easy release of gas from the stomach. Nausifar MPS Tablet is taken without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect, or be affected by this medicine. The most common side effects are dryness in mouth, diarrhea, weakness, restlessness, and tremor. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. It may also cause sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid drinking alcohol while taking this medicine as it can worsen your sleepiness. Before taking this medicine, you should tell your doctor if you are pregnant, planning pregnancy or breastfeeding. You should also tell your doctor if you have any kidney diseases so that your doctor can prescribe a suitable dose for you.
  • Diarrhea
  • Weakness
  • Parkinson-like symptoms
  • Sleepiness
  • Restlessness
  • Tremors
  • Depression
  • Muscle stiffness
Alcohol : UNSAFE

It is unsafe to consume alcohol with Nausifar MPS Tablet.

Pregnancy : SAFE IF PRESCRIBED

Nausifar MPS Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding : CONSULT YOUR DOCTOR

Nausifar MPS Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving : UNSAFE

Nausifar MPS Tablet may cause side effects which could affect your ability to drive. Nausifar MPS Tablet may cause drowsiness, dizziness, dyskinesia and dystonias which could affect the vision and may interfere with the ability to drive.

Kidney : CAUTION

Nausifar MPS Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nausifar MPS Tablet may be needed. Please consult your doctor.

Liver : SAFE IF PRESCRIBED

Nausifar MPS Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nausifar MPS Tablet may not be needed in these patients. Please consult your doctor.

If you miss a dose of Nausifar MPS Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Habit Forming::No|Therapeutic Class::GASTRO INTESTINAL

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Metoclopramide (5mg) + Simethicone (125mg)

Test Buy medical disposable face mask
to protect your loved ones